SCHEMBL425064

SCHEMBL425064

N#C/C(=N\O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2519157 1.00
SCHEMBL425065 1.00
SCHEMBL3067270 0.77
SCHEMBL3067267 0.77
SCHEMBL3067274 0.77
SCHEMBL2723133 0.74
Potassium Ion SCHEMBL18640391 0.74
SCHEMBL9464704 0.74
SCHEMBL9464708 0.74
Potassium Ion SCHEMBL18640390 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4384501-A1 PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF Glenmark Life Sciences Limited (IN) 2024-06-19 EP claimed
EP-4349840-A2 PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-04-10 EP claimed
WO-2023194924-A1 PROCESS FOR PREPARATION OF RELUGOLIX GLENMARK LIFE SCIENCES LIMITED (IN) 2023-10-12 WO claimed
WO-2023017393-A1 PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF GLENMARK LIFE SCIENCES LIMITED (IN) 2023-02-16 WO claimed
EP-3450439-B1 METHOD FOR PRODUCING MONOMER FOR SINGLE-STRANDED NUCLEIC ACID MOLECULE SUMITOMO CHEMICAL CO (JP) 2021-01-20 EP claimed
US-10786690-B2 Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof Temisis (FR) 2020-09-29 US claimed
US-10308672-B2 Method for producing monomer for single-stranded nucleic acid molecule SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-06-04 US claimed
US-20190100540-A1 METHOD FOR PRODUCING MONOMER FOR SINGLE-STRANDED NUCLEIC ACID MOLECULE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-04-04 US claimed
WO-2017186779-A1 AMIDE DERIVATIVES OF POLYCAFFEOYLQUINIC ACIDS, PROCESS FOR PRODUCING SAME AND USES THEREOF PLANT ADVANCED TECHNOLOGIES PAT (FR) 2017-11-02 WO claimed
EP-1923398-B1 Process for producing a polypeptide CHISSO CORP (JP) 2011-01-05 EP claimed
EP-1340767-B1 Polypeptide useful as biomaterial and process for producing the same PHG CORP (JP) 2009-01-28 EP claimed
US-20080300218-A1 CROSSLINKABLE POLYSACCHARIDE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, CROSSLINKABLE POLYSACCHARIDE COMPOSITION, AND MEDICAL TREATMENT MATERIAL TERUMO KABUSHIKI KAISHA (JP) 2008-12-04 US claimed
EP-1923398-A1 Process for producing a polypeptide PHG Corporation (JP) 2008-05-21 EP claimed
US-20080009604-A1 Novel polypeptide and process for producing the same UNIQS CORPORATION (JP) 2008-01-10 US claimed
US-20070207955-A1 Novel polypeptide and process for producing the same, and collagenase inhibitor PHG CORPORATION (JP) 2007-09-06 US claimed
US-7262275-B2 Polypeptide and process for producing the same PHG CORPORATION (JP) 2007-08-28 US claimed
EP-1340767-A2 Polypeptide useful as biomaterial and process for producing the same CentMed Inc. (JP) 2003-09-03 EP claimed
US-20030162941-A1 Novel polypeptide and process for producing the same UNIQS CORPORATION (JP) 2003-08-28 US claimed
EP-0460446-B1 COUPLING AGENT FOR PEPTIDE SYNTHESIS HOECHST AKTIENGESELLSCHAFT (DE) 1993-04-07 EP claimed
US-4079147-A Fungicidally active derivatives of carbamic acid oxime-esters of isonitrosocyanoacetic acid BAYER AKTIENGESELLSCHAFT (DT) 1978-03-14 US claimed